6 results
Recurrent / Breakthrough DVT During Anticoagulation

Subtherapeutic Anticoagulation
Hypercoagulable State 
 - Antithrombin deficiency 
 - Hypercoagulability ot
/ Breakthrough DVT ... Structural - Pelvic masses ... Breakthrough #Recurrent #DVT ... #hematology #differential ... #algorithm
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... DVT = deep vein ... #Cancer #Algorithm ... #Anticoagulation ... #Management #Hematology
â–º
Causes of Breakthrough/Extension of Thrombosis and Management Algorithm

#Anticoagulation #Breakthrough #Thrombosis #Algorithm #Extension #VTE #DVT #Hematology #Management
Algorithm #Anticoagulation ... Extension #VTE #DVT ... #Hematology #Management ... #Diagnosis #Differential ... #Causes
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
and incidental DVT ... without concomitant DVT ... DOAC, direct oral ... #Anticoagulation ... #Management #Hematology
Myelodysplastic Syndromes (MDS)

What?
Myelodysplastic syndromes are a group of disorders caused by blood cells that are poorly
just beneath the skin ... hematopoiesis cell lineages—erythrocytic ... syndromes with single-lineage ... blood count with differential ... Syndromes #diagnosis #hematology
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
MI, stroke, DVT/ ... megakaryocyte lineage ... Thrombocythemia #ET #hematology ... #diagnosis #management ... #hematology